Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Pharmaceuticals policy Stories

2014-04-16 08:38:32

The site will be free to all subscribers and will allow users to converse without it showing up on their home or work computers. The project will be over a 60 day trial period. SCOTTSDALE, Ariz., April 16, 2014 /PRNewswire/ -- Northsight Capital, Inc., (NCAP OTCBB) announced today an informal joint venture arrangement with the owner of TheAnonymousEmail.com to develop and promote, on a trial basis, the use of the anonymous emailing system by persons discussing, debating, or...

2014-04-16 08:34:30

HAYWARD, Calif., April 16, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of authorized generic RENVELA (sevelamer carbonate 800 mg tablets), through Global Pharmaceuticals, Impax's generics division. RENVELA is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. http://photos.prnewswire.com/prnvar/20140402/PH96035LOGO Under the terms of a settlement agreement, Genzyme,...

2014-04-16 08:30:45

ALBANY, New York, April 16, 2014 /PRNewswire/ -- ResearchMoz.us includes new market research report "The Pharmaceutical Market [http://www.researchmoz.us/pharmaceutical-market-reports-38.html ]: Greece, Denmark, Bahrain, Sri Lanka and Czech Republic "to its huge collection of research reports. The macroenvironment for the Danish pharmaceutical industry is improving.The centre-left coalition, of the Social Democratic Party, the Socialist People's Party and the Social...

2014-04-15 08:30:49

Continued dialogue needed to make a tangible difference OTTAWA, April 15, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, reaffirmed her commitment to tackle the growing problem of prescription drug abuse head on. The Government of Canada will continue to work with groups like the Canadian Centre on Substance Abuse, different levels of government, doctors, pharmacists, First Nations representatives, law enforcement and addictions specialists to help combat...

2014-04-15 08:29:42

DUBLIN, April 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mylan Inc. and Famy Care Ltd. to settle all outstanding patent litigation related to Mylan's generic version of Generess(®) FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets). Under the terms of the agreement, Actavis will grant Mylan a license to market its generic version of Generess(®) FE under its pending Abbreviated New Drug...

2014-04-15 08:20:58

The Global Piracy and Counterfeiting Consultants plans to help the US Postal Service stop delivering counterfeit Chinese pharmaceutical products via the US mail and urges US consumers to use caution when purchasing pharmaceutical items through the Internet. WASHINGTON, April 15, 2014 /PRNewswire/ -- The Global Piracy and Counterfeiting Consultants is now offering to help the US Postal Service to stop delivering Chinese counterfeit pharmaceutical products via the US mail, because Chinese...

2014-04-14 16:24:28

LONDON, April 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:China Pharmaceuticals and Healthcare Report Q1 2014Includes 3 FREE quarterly updatesBMI View:Multinational pharmaceutical firms' commitment to the Chinese market is underpinned by thepotential of the healthcare sector. The sector itself is supported by consistent government efforts, therebyincreasing patients' access to these drugs. We would also highlight risks of operating in China, such as...

2014-04-14 12:33:48

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 14, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Eli Lilly and Co. (NYSE: LLY), Medtronic Inc. (NYSE: MDT) and Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary...

2014-04-14 12:33:11

PDUFA goal date set for September 26, 2014 ATLANTA, April 14, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that its recent resubmission of the New Drug Application (NDA) for ILUVIEN(®) has been acknowledged as received by the U.S. Food and Drug Administration (FDA) as a complete class 2 response to the...

2014-04-12 23:02:45

MCN and the Chicago Compassion Club have teamed together to satisfy an influx of Illinois pain patients seeking alternative medicine through a high-visibility marketing campaign. As a licensed alternative health clinic in Chicago, this medical marijuana certification center is set to help Illinois achieve wellness. (PRWEB) April 12, 2014 The Chicago Compassion Club is an alternative organization based out of Chicago, Illinois. The group is the first of its kind in Illinois and is...